Results 41 to 50 of about 15,299 (207)

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

echocardiographic examinations after endomyocardial biopsy

, 2011
Das Auftreten von Perikardergüssen als Zeichen einer traumatisch bedingten Ventrikelperforation nach Endomyokardbipsie als schwerste auftretende Komplikation mit Ausbildung einer Perikardtamponade wurde anhand von 723 Fällen nach Häufigkeit und Klinik ...
Wohlmann, Christoph (130539694)
core   +1 more source

Myocardial Immunocompetent Cells and Macrophage Phenotypes as Histopathological Surrogates for Diagnosis of Cardiac Sarcoidosis in Japanese

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundThe histological diagnosis of cardiac sarcoidosis (CS) is based on the presence of myocardial granulomas; however, the sensitivity of endomyocardial biopsy is relatively low.
Yasuyuki Honda, Toshiyuki Nagai, Yoshihiko Ikeda, Mamoru Sakakibara, Naoya Asakawa, Nobutaka Nagano, Michikazu Nakai, Kunihiro Nishimura, Yasuo Sugano, Keiko Ohta‐Ogo, Yasuhide Asaumi, Takeshi Aiba, Hideaki Kanzaki, Kengo Kusano, Teruo Noguchi, Satoshi Yasuda, Hiroyuki Tsutsui, Hatsue Ishibashi‐Ueda, Toshihisa Anzai   +18 more
doaj   +1 more source

“Borderline” myocarditis: An indication for repeat endomyocardial biopsy

, 1990
Repeat endomyocardial biopsy was performed in 28 patients with dilated cardiomyopathy of ≤12 months' duration and either symptomatic heart failure or life-threatening ventricular arrhythmias.
Dec, G. William, Fallon, John T., Palacios, Igor, Southern, James F.   +3 more
core   +1 more source

The challenge to detect heart transplant rejection and transplant vasculopathy non-invasively – a pilot study

Journal of Cardiothoracic Surgery, 2009
Background Cardiac allograft rejection and vasculopathy are the main factors limiting long-term survival after heart transplantation. In this pilot study we investigated whether non-invasive methods are beneficial to detect cardiac allograft rejection ...
Helber Uwe, Schroeder Stephen, Aebert Hermann, Burgstahler Christof, Usta Engin, Kopp Andreas F, Ziemer Gerhard   +6 more
doaj   +1 more source

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes, Florian Buehning, Tobias Lerchner, Julia Vogel, Raluca I. Mincu, Matthias Totzeck, Tienush Rassaf, Lars Michel   +7 more
wiley   +1 more source

Endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy: A case report

, 2007
Endomyocardial Biopsy Guided by Voltage Mapping. A positive endomyocardial biopsy (EMB) is a major diagnostic criterion for arrhythmogenic right ventricular cardiomyopathy (ARVC).
Re, Federica, Francesco Laurenzi, Claudio Tondo, Avella, Andrea, Zecchi, Paolo, Augusto Pappalardo, Andrea Avella, Elisabetta Zachara, Laurenzi, Francesco, Pappalardo, Augusto, Mancini, Massimiliano, Massimiliano Mancini, Paolo Zecchi, C. Tondo, A. Dello Russo, Russo, Antonio Dello, Federica Re, D'AMATI, Giulia, GIULIA D'AMATI, ANTONIO DELLO RUSSO, Zachara, Elisabetta   +20 more
core   +2 more sources

Diagnostic yield, safety and therapeutic consequences of myocardial biopsy in clinically suspected fulminant myocarditis unweanable from mechanical circulatory support

Annals of Intensive Care, 2023
Background Fulminant myocarditis is a rare and severe disease whose definite and etiological diagnoses rely on pathological examination. Albeit, myocardial biopsy can be associated with significant morbidity and mortality, its therapeutic consequences ...
Yann Marquet, Guillaume Hékimian, Guillaume Lebreton, Mathieu Kerneis, Philippe Rouvier, Pierre Bay, Alexis Mathian, Nicolas Bréchot, Juliette Chommeloux, Matthieu Petit, Melchior Gautier, Lucie Lefevre, Ouriel Saura, David Levy, Paul Quentric, Quentin Moyon, Sofia Ortuno, Matthieu Schmidt, Pascal Leprince, Charles-Edouard Luyt, Alain Combes, Marc Pineton de Chambrun   +21 more
doaj   +1 more source

Evaluation of contemporary echocardiographic and histomorphology parameters in predicting mortality in patients with endomyocardial biopsy-proven cardiac AL amyloidosis

Frontiers in Cardiovascular Medicine, 2023
IntroductionThis study examined the role of echocardiographic and cardiac histomorphology parameters in predicting mortality in patients with cardiac AL amyloidosis.MethodsPatients with endomyocardial biopsy-proven cardiac AL amyloidosis treated at MD ...
Efstratios Koutroumpakis, Adam Niku, Christopher K. Black, Abdelrahman Ali, Humaira Sadaf, Juhee Song, Nicolas Palaskas, Cezar Iliescu, Jean-Bernard Durand, Syed Wamique Yusuf, Hans C. Lee, L. Maximilian Buja, Anita Deswal, Jose Banchs   +13 more
doaj   +1 more source

Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...
Raluca I. Mincu, Lisa Zimmer, Dimitra Vlachopoulou, Elias Haj‐Yehia, Julia Hoffmann, Lars Michel, Elisabeth Livingstone, Dirk Schadendorf, Alpaslan Tasdogan, Matthias Totzeck, Tienush Rassaf   +10 more
wiley   +1 more source